VOLITIONRX LTD — Director's Dealing 2017

Oct 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-10-18

Reporting Person: TERRELL JASON BRADLEY MD (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-18	Warrant (Right to Buy)	$2.47	A	25000	Acquired	2020-09-18	Common Stock (25000)	Direct

Footnotes

F1: The vesting criteria of one installment of a Warrant granted to the reporting person on March 20, 2013, was deemed met pursuant to approval of the Compensation Committee of the Issuer effective October 18, 2017, resulting in vesting of the Warrant as to 25,000 shares effective September 18, 2017. The vested shares shall expire three years after the vesting date.